Madrigal Pharmaceuticals (MDGL) PT Raised to $536 at BofA Securities
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $512.94 +0.01%
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Join SI Premium – FREE
BofA Securities analyst Jason Zemansky raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $536.00 (from $529.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Take-Two Interactive (TTWO) PT Raised to $368 at BofA Securities
- Darling Ingredients (DAR) PT Lowered to $70 at TD Cowen
- Cytokinetics (CYTK) PT Raised to $118 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
